Synergistic effect of a combination of nanoparticulate Fe₃O₄ and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells

References

• LiuAChenHWeiWAntiproliferative and antimetastatic effects of emodin on human pancreatic cancerOncol Rep201126818921491088
   PubMed Web of Science ®Google Scholar
• MaimonYKaraushVYaal-HahoshenNEffect of Chinese herbal therapy on breast cancer adenocarcinoma cell linesJ Int Med Res2010382033203921227007
   PubMed Web of Science ®Google Scholar
• LiQChengHZhuGGambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arrestingBiol Pharm Bull20103341542020190402
   PubMed Web of Science ®Google Scholar
• MuRLuNWangJAn oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitroEur J Cancer Prev201019616719934761
   PubMed Web of Science ®Google Scholar
• GuHRaoSZhaoJGambogic acid reduced Bcl-2 expression via p53 in human breast MCF-7 cancer cellsJ Cancer Res Clin Oncol20091351777178219582475
   PubMed Web of Science ®Google Scholar
• YiTYiZChoSGGambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signalingCancer Res2008681843185018339865
   PubMed Web of Science ®Google Scholar
• WangTTWeiJQianXPDingYTYuLXLiuBRGambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cellsCancer Lett200826221422218248784
   PubMed Web of Science ®Google Scholar
• LuNYangYYouQDGambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1Cancer Lett2007258808917920764
   PubMed Web of Science ®Google Scholar
• LiRChenYZengLLGambogic acid induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cellsToxicology20092629810519433130
   PubMed Web of Science ®Google Scholar
• ChengFYSuCHYangYSCharacterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applicationsBiomaterials20052672973815350777
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
   PubMed Web of Science ®Google Scholar
• MartinWNatural and synthetic polymers as inhibitors of drug efflux pumpsPharm Res20082550051117896100
   PubMed Web of Science ®Google Scholar
• ChenBALaiBBChengJDaunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivoInt J Nanomedicine2009420120819918366
   PubMed Web of Science ®Google Scholar
• SunQChenBAWangXMPreparation of Fe3O4-magnetic nanoparticles loaded with adriamycin and its reversal of multidrug resistance in vitroZhongguo Shi Yan Xue Ye Xue Za Zhi200715748751 Chinese.17708796
   PubMedGoogle Scholar
• WangXZhangRWuCThe application of Fe3O4 nanoparticle in cancer research: a new strategy to inhibit drug resistanceJ Biomed Mater Res A.200780A85286017072850
   PubMed Web of Science ®Google Scholar
• ChenBALiangYQWuWWSynergistic effect of magnetic nanoparticles of Fe3O4 with gambogic acid on apoptosis of K562 leukemia cellsInt J Nanomedicine2009425125920011242
   PubMed Web of Science ®Google Scholar
• SchatzJHTargeting the PI3K/AKT/mTOR pathway in non-Hodgkin’s lymphoma: results, biology, and development strategiesCurr Oncol Rep20111339840621755275
   PubMed Web of Science ®Google Scholar
• BrazilDPHemmingsBATen years of protein kinase B signalling: a hard Akt to followTrends Biochem Sci20012665766411701324
   PubMed Web of Science ®Google Scholar
• RychahouPGJacksonLNSilvaSRRajaramanSEversBMTargeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinomaAnn Surg200624383384216772787
   PubMed Web of Science ®Google Scholar
• KhaleghpourKLiYBanvilleDInvolvement of the PI3-kinase signaling pathway in progression of colon adenocarcinomaCarcinogenesis20042524124814578160
   PubMed Web of Science ®Google Scholar
• JohnsonSMGulhatiPRampyBANovel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancerJ Am Coll Surg201021076776820421047
   PubMed Web of Science ®Google Scholar
• WangJKuropatwinskiKHauserJColon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosisMol Cancer Ther200761143115017363507
   PubMed Web of Science ®Google Scholar
• LiuYChenLKoTCFieldsAPThompsonEAEvi1 is a survival factor which conveys resistance to both TGF-β and Taxol-mediated cell death via PI3K/AktOncogene2006253565357516462766
   PubMed Web of Science ®Google Scholar
• RoulinDCerantolaYDormond-MeuwlyADemartinesNDormondOTargeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivoMol Cancer201095720226010
   PubMed Web of Science ®Google Scholar
• ZhaoWZhouSFZhangZPXuGPLiXBYanJLGambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrestOncol Rep2011251289129521331449
   PubMed Web of Science ®Google Scholar
• ZhangLYiYChenJGambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cellsBiochem Biophys Res Commun201040328228721074517
   PubMed Web of Science ®Google Scholar
• Fernandez-PachecoRValdiviaJGIbarraMRMagnetic nanoparticles for local drug delivery using magnetic implantsMethods Mol Biol200954455956919488723
   PubMedGoogle Scholar
• DartonNJHallmarkBHanXPalitSSlaterNKMackleyMRThe in-flow capture of super-paramagnetic nanoparticles for targeting therapeuticsNanomedicine20084192918093881
   PubMed Web of Science ®Google Scholar
• WuWWChenBAChengJBiocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignanciesInt J Nanomedicine201051079108421170355
   PubMed Web of Science ®Google Scholar
• SembaSItohNItoMHaradaMYamakawaMThe in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3′-kinase, in human colon cancer cellsClin Cancer Res200281957196312060641
   PubMed Web of Science ®Google Scholar
• YamaguchiKLeeSHElingTEBaekSJIdentification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathwayJ Biol Chem2004279496174962315377673
   PubMed Web of Science ®Google Scholar
• DattaSRBrunetAGreenbergMECellular survival: a play in three AktsGenes Dev1999132905292710579998
   PubMed Web of Science ®Google Scholar
• GaoNFlynnDCZhangZG1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cellsAm J Physiol Cell Physiol2004287C281C29115028555
   PubMed Web of Science ®Google Scholar
• LiuPChengHRobertsTMZhaoJJTargeting the phosphoinositide 3-kinase pathway in cancerNat Rev Drug Discov2009862764419644473
   PubMed Web of Science ®Google Scholar
• DattaSRDudekHTaoXGreenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machineryCell1997912312419346240
   PubMed Web of Science ®Google Scholar
• ZhaJHaradaHYangEJockelJKorsmeyerSJSerine phosphory-lation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XLCell1996876196288929531
   PubMed Web of Science ®Google Scholar
• KimMRJeongEGChaeBPro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomasDig Dis Sci2007522751275617393317
   PubMed Web of Science ®Google Scholar
• YipWKLeongVCAbdullahMAYusoffSSeowHFOverexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinomaOncol Rep20081931932818202777
   PubMed Web of Science ®Google Scholar
• ZimmermannKCBonzonCGreenDRThe machinery of programmed cell deathPharmacol Ther200192577011750036
   PubMed Web of Science ®Google Scholar